Abstract
Murine caspase-11 is the centerpiece of the non-canonical inflammasome pathway that can respond to intracellular LPS and induce pyroptosis. Caspase-11 contains two components, an N-terminal caspase recruitment domain (CARD) and a C-terminal catalytic domain. The aggregation of caspase-11 is thought to promote the auto-processing and activation of caspase-11. However, the activation mechanism of caspase-11 remains unclear. In this study, we purified the caspase-11 CARD fused to an MBP tag and found it tetramerizes in solution. Crystallographic analysis reveals an extensive hydrophobic interface formed by the H1–2 helix mediating homotypic CARD interactions. Importantly, mutations of the helix H1–2 hydrophobic residues abolished the tetramerization of MBP-tagged CARD in solution and failed to induce pyroptosis in cells. Our study provides the first evidence of the homotypic interaction mode for an inflammatory caspase by crystal model. This finding demonstrates that the tetramerization of the N-terminal CARD can promote releasing of the catalytic domain auto-inhibition, leading to the caspase-11 activation.
Subject terms: Innate immunity, X-ray crystallography
Introduction
Inflammasome signaling pathways sense different body injuries and pathogen infections, and are essential components of the innate immune system1. Unlike several NOD-like receptors (NLRs) and AIM2-like receptors (ALRs) that, in response to certain Pathogen Associated Molecular Pattern (PAMPs), form a canonical inflammasome complex for activation caspase-1, the non-canonical pathway can directly respond to the cytosolic bacterial lipopolysaccharide (LPS), a molecule that plays an important role in endotoxic shock2–8.
Murine caspase-11 and its human orthologs caspase-4/5 are essential for the non-canonical inflammasome pathway9. Sensing of cytoplasmic LPS results in the self-cleavage and activation of caspase-1110. The activated caspase can then drive the canonical inflammasome pathway to induce pyroptosis9,11–13. The activation of caspase-11 is involved in the development of inflammatory responses, such as lethal sepsis, making it an important target for drug development10.
Caspase-11, -4, and -5 belong to a family of aspartate-specific cysteine proteases. Their activation requires oligomerization and autoproteolysis. Caspase-11, -4, and -5 contain an N-terminal death fold named caspase recruitment domain (CARD) and a C-terminal catalytic domain14. The CARD mediates caspase oligomerization through CARD–CARD interaction. Then, proximity-induced autoproteolysis separates the pro-domain from the catalytic domain (p30) and further separates the catalytic domain into a large and a small catalytic unit (p20 and p10), activating the caspase protein15,16. The CARD of caspase-11 was found to be essential for LPS-induced pyroptosis11. However, the structural mechanism of the caspase-11 CARD–CARD interactions remains unexplored.
Here we describe the crystal structure of caspase-11 CARD. The structure reveals that the caspase-11 CARD undergoes tetramerization mediated by the hydrophobic interface in the H1–2 helix. Further mutagenesis experiments suggest that the hydrophobic interface is critical for the oligomerization of CARD and self-cleavage of caspase-11 in cells.
Results
MBP-tagged caspase-11 CARD exists as tetramers in solution
The functional motif of caspase-11 CARD is reported to reside in amino acid residues 1–59 of caspase-11 protein11, although the canonical CARD region is predicted to be within residues 1–80. To characterize the biochemical behavior, we generated an expression construct encoding the first 101 amino acids (aa1–101) of caspase-11 with an maltose-binding protein (MBP) tag on the N terminus (WT-CARDaa1–101). When purified from Escherichia coli, the WT-CARDaa1–101 with the MBP tag eluted with two peaks in a size-exclusion chromatogram (SEC). One peak represents polymers, probably resulting from misfolded samples, and the other represents a smaller sized species corresponding to a monomer (Fig. 1a). We further collected the protein samples in each peak to analyze their oligomerization states by static light scattering. The pooled monomer peak sample demonstrated a dynamic re-distribution between two different species (Fig. 1b, c), corresponding to tetramers and monomers (Fig. 1d). The continuous sedimentation coefficient distributions curves, c(s), for WT-CARDaa1–101 from monomer peak in SEC was obtained. The molecular weight of each peaks revealed a state switch from monomer to homodimer and homotetramer of WT-CARDaa1–101, which also showed the state switch of WT-CARDaa1–101 was in a concentration-dependent manner (Fig. 1e). Interestingly, the deletion of the first ten amino acids on the N terminus led to a stable monomer of CARDaa11–101 in solution (Fig. 1c).
Overall structure of the caspase-11 CARD in crystal
The crystal structure of the caspase-11 CARD (residues 11–101) was determined at a resolution of 2.8 Å using X-ray crystallography with an N-terminal MBP as a crystallization tag (Table 1). This technique has been used successfully in the structure determination of several death domains17,18. As shown in Fig. 2a, the caspase-11 CARD contains four chains in one asymmetric unit (chain A, B, C, D). The structure of caspase-11 CARD displays a unique feature that is distinct from all known death domain superfamily members (Fig. 2a), it is composed of four amphipathic α-helices instead of the classical six19. Comparison with the classic CARD structure reveals that, in the caspase-11 CARD, the classical helix H1 is fused with H2 to form a long helix that we named as H1–2. The three short helices following the H1–2 are well superimposable with the H3, H4, and H5 of classical death folds, but sequence alignment of the CARD domains shows that helices H1 to H5 are not highly conserved even among the homologous proteins (Fig. 2b, c). H6 cannot be observed in our crystal model (Fig. 2b).
Table 1.
No. of reflections (total/unique) | 302,171/51,251 |
Space group | P212121 |
Redundancya | 5.89 (5.77) |
Unit cell parameters | |
a, b, c (Å) | 77.31, 145.16, 187.72 |
α, β, γ (°) | 90, 90, 90 |
No. of measured reflections | 302,171 (45,074) |
No. of unique reflections | 51,251 (7804) |
Completeness (%)a | 97.3 (92.9) |
I/σ (I)a | 20.64 (2.03) |
R-meansa | 0.069 (0.826) |
CC (1/2)a | 0.999 (0.808) |
Refinement | |
Resolution (Å) | 50–2.8 |
No. of protein atoms | 12,882 |
R.m.s.d. bond lengths (Å) | 0.011 |
R.m.s.d. bond angles (°) | 1.173 |
Rwork (%)b | 30.55 |
Rfree (%)c | 34.01 |
Wilson B-factor | 84.15 |
Ramachandran plot (favored/disallowed) | 92.3/1.22 |
PDB code | 6KXG |
Values in parentheses are for the highest-resolution shell.
aRmeans = Σh(n/n − 1)1/2 Σi |Ii(h) − <I(h)>| / ΣhΣiIi(h), where Ii(h) and <I(h)> are the ith and the mean measurement, respectively, of the intensity of reflection h.
bRwork = Σh ||Fobs (h)| − |Fcalc (h)|| / Σh | Fobs (h)|, where Fobs (h) and Fcalc (h) are the observed and calculated structure factors, respectively. No I/σ cutoff was applied.
cRfree is the R-value obtained from a test set consisting of a randomly selected 5% subset of the data. The test set is excluded from refinement.
The electrostatic surface analysis of the CARD with acidic, basic, and hydrophobic patches indicates that several neutral amino acids in the long H1–2 (residues L372–S391) form a hydrophobic surface, which possibly mediates the oligomerization of CARD (Fig. 2d). Moreover, the interactions between the four protomers are primarily mediated by H1–2 (Fig. 2e). PISA (Proteins, Interfaces, Structures, Assemblies) server20 was used to analysis the molecular interface in the structure. We found that the interface area between chain B and chain C is 1058.2 Å2, whereas the area is 993.0 Å2 between chain A and chain D, with a negative ΔiG indicating a strong hydrophobic interaction between two chains. Although the interface area reduced sharply between chain A and chain B, and between chain C and chain D, the area is even less between chain A and chain C, and between chain B and chain D, suggesting that B/C and A/D formed homodimers before aggregating into a tetramer (Table 2). The presence of homodimer and homotetramer are also revealed by sedimentation velocity analytical ultracentrifugation (SV-AUC) analysis of WT-CARDaa1–101 (Fig. 1e). All of these intermolecular interactions are primarily mediated by the H1–2 helix. Collectively, these data suggest the H1–2 of the caspase-11 CARD reveals by crystal structure might be involved in the self-interaction of caspase-11 CARD.
Table 2.
Structure1 : Structure2 | Interface area (Å2) | ΔiG (kcal/mol) | ΔiG P-value |
---|---|---|---|
Chain C : Chain B | 1058.2 | –18.7 | 0.361 |
Chain A : Chain D | 993.0 | –20.2 | 0.226 |
Chain A : Chain B | 241.0 | –5.8 | 0.296 |
Chain C : Chain D | 224.9 | –4.8 | 0.210 |
Chain D : Chain B | 83.1 | –2.7 | 0.143 |
Chain A : Chain C | 82.1 | –2.6 | 0.093 |
ΔiG indicates the solvation free energy gain upon formation of the interface, in kcal/mol. Negative ΔiG indicates hydrophobic interfaces or positive protein affinity. This value does not include the effect of the satisfied hydrogen bonds and salt bridges across the interface.
P > 0.5 means that the interface is less hydrophobic than it should be, therefore the interface is likely to be an artifact of crystal packing. P < 0.5 indicates the interface has a higher hydrophobicity than the predicted average for a given structure, implying that the interface surface may be interaction-specific. The limiting case of P = 0 means that no other interface of the observed area may have a lower ΔiG; therefore, this interface is a truly unique spot on the protein surface.
Mutations in the hydrophobic interface abolish the aggregation of caspase-11 in vitro
To investigate whether the activation of caspase-11 relies on the homotypic interaction of CARD as observed in the crystal structure, we generated four mutations, V13A, L14A, L17A, V21A (VLLV) on the H1–2. These residues are all located in the N-terminal side of CARD domain in order to destroy the hydrophobic interaction (Fig. 3a). Compared with the charge mutation K19E, which positions in the middle of helix H1–2 (Fig. 3b) as mentioned in a previous study11, VLLV mutations on the caspase-11 CARD only change the side chains of the hydrophobic amino acids, but not their charges. C254A-caspase-11 containing the VLLV or K19E mutations in their H1–2s with the MBP tag, when purified from E. coli, were both eluted as monomers from the gel-filtration columns, whereas the MBP-caspase-11 protein carrying only the C254A mutation retained its ability to form oligomer with multiple polymerization states (Fig. 3c). This result demonstrates that the hydrophobic region of the CARD is required for the oligomerization of caspase-11.
The abolished oligomerization ability in H1–2 mutant caspase-11 proteins prompted us to hypothesize that these mutations may also affect caspase-11 activation. A previous report showed that the wild-type caspase-11 protein failed to express in E. coli system13. Considering this, we used an MBP tag to stabilize caspase-11 in E. coli to investigate the caspase-11 activation. A ~37 kDa fraction was eluted from an analytical gel-filtration column and the fraction was further separated into two bands on an SDS gel (Fig. 3d). With N-terminal sequencing and mass spectrum, we confirmed that the bands on the SDS gel were the p10 and p20 subunits of the caspase-11 catalytic domain (Fig. 3e). The natural cleavage site of CARD is between the 59th and the 60th residue of caspase-11, and the two mature subunits of the catalytic domain (p30), p20 and p10, span residues 60–266, and 286–373, respectively (Fig. 3f). Activated caspase-11 cleaves gasdermin D (GSDMD) that can lead to pyroptosis and interleukin-1β maturation11,12. Therefore, to directly test the proteolytic activities in the wild-type and VLLV mutant caspase-11, we synthesized a self-quenched fluorescent peptide DABYL-GQLSLLSDGID-glu(edans) that mimics the GSDMD cleavage site for caspase-11. This peptide can be used as a reporter for caspase-11 proteolytic activity (GSDMD cleavage reporter). We incubated auto-proteolytic wild-type p30 protein fraction with the GSDMD cleavage reporter. With the increased ratio of p30 to the GSDMD cleavage reporter, the fluorescent product increased, indicating that the fraction is proteolytically active (Fig. 3g). Then, we introduced the VLLV mutations to the wild-type caspase-11 and purified the protein from E. coli (VLLV-caspase-11). SDS-polyacrylamide gel electrophoresis analysis showed that the VLLV mutation reduced the self-cleavage of full-length caspase-11 (Fig. 3h). Furthermore, we found that the proteolytic activity of VLLV-caspase-11 was greatly reduced (Fig. 3i). These results show that the VLLV mutation on CARD not only affect the aggregation of caspase-11 but also inhibit the cleavage of caspase-11 itself and substrates.
Together, these data indicate that the hydrophobic interface on the CARD helix H1–2 region is essential for the aggregation of caspase-11 that leads to caspase maturation and downstream signal cascade activation.
Caspase-11-mediated GSDMD cleavage and cell death are dependent on the hydrophobic surface on H1–2 of CARD
As we found that purified VLLV-caspase-11 fails to activate, we further sought to evaluate the activity of wild-type and mutant caspase-11 in cells. As caspase-4 is not expressed in HEK293T cells (Supplementary Fig. S1), we co-transfected hGSDMD with full-length caspase-11 plasmids, i.e., WT-caspase-11, VLLV-caspase-11, K19E-caspase-11, or C254A-caspase-11, into HEK293T cells. Without any stimulation, WT-caspase-11 underwent self-activation, then the hGSDMD was cleaved into two fragments (Fig. 4a). In addition, cell death was significantly upregulated (Fig. 4b). In summary, compared to WT-caspase-11, C254A-caspase-11 displayed a drastic decrease in the hGSDMD cleavage and cell death, and the VLLV-caspase-11 mutant displayed a partial decrease in both GSDMD cleavage and cell death.
We further tested whether the overexpressed wild-type and mutant caspase-11 could nucleate oligomeric assemblies of the caspase-11 protein. For this, we constructed wild-type and mutant caspase-11 expression plasmids tethered with enhanced green fluorescent protein (EGFP) on the C terminus (WT-caspase-11-EGFP, VLLV-caspase-11-EGFP, and C254A-caspase-11-EGFP). When transfecting 293T cells with WT-caspase-11-EGFP or C254A-caspase-11-EGFP, we observed caspase-11-EGFP specks that indicate caspase-11 aggregations. In comparison, significantly less percentage of cells transfected with the VLLV-caspase-11-EGFP had caspase-11-EGFP specks (Fig. 4c, d). These results demonstrate that the caspase-11-CARD mutations can affect the oligomerization and the activation of caspase-11 in cells.
LPS does not associate with the MBP-tagged caspase-11 CARD domain in solution
The above results showed that the homotypic CARD interaction interface is critical for caspase-11 activation and overexpressing caspase-11 proteins in HEK293T cells could directly activate the non-canonical inflammasome signaling pathway without LPS stimulation through CARD-mediated oligomerization of caspase-11. Previous research suggests that the LPS binds to the CARD domain of caspase-4, which promotes caspase-4 activation11, but another research indicates that LPS binding requires both CARD and catalytic domain of caspase-1121. We next tested whether LPS is required for the aggregation of caspase-11 CARD in solution. The deletion of residues 1–59 of caspase-11 was shown to compromise the LPS-induced caspase-11 activation11. Here we used the MBP fusion protein to stabilize the caspase-11 CARD and the mutant VLLV-CARD in the E. coli expression system, with a ~10 residue linker (TEV cleavage sequence) between MBP and caspase-11 CARD proteins. Caspase-11 CARDaa11–101 and VLLV-CARDaa11–101 formed monomers during purification, which was confirmed by SEC-multi-angle light scattering (MALS) (size-exclusion chromatography followed by MALS (Fig. 5a, b). After incubation with LPS at 4 °C for 4 h, the gel-filtration profile displayed no change (Fig. 5c). Compared with VLLV-CARDaa11–101, both proteins failed to respond to LPS stimulation (Fig. 5d). Similar to WT-CARDaa11–101 and VLLV-CARDaa11–101, LPS failed to induce the polymerization of WT-CARDaa1–101 and VLLV-CARDaa1–101 (Fig. 5e, f). These data led to the conclusion that LPS does not directly bind with MBP-tagged caspase-11 CARD, despite that it is able to form functional related homo-oligomers.
Truncations of caspase-11 CARD result in different dynamic state and which is in a linker sequence independent manner
For crystallization, we used N-terminal 10 amino acids deficient CARD (11–101 residues), but it stays as monomer in solution during purification (Fig. 1d). To find out whether CARD aggregation requires all of the residues in the CARD domain, we made several truncations of WT-CARD, WT-CARDaa1–59, and WT-CARDaa11–59 due to the natural cleavage site of caspase-11 (Fig. 3e). Unfortunately, we failed to obtain the crystal structure of different truncations of CARD. Therefore, we decided to determine the mechanism of oligomerization of CARD based on their structural characteristics. WT-CARDaa1–101 showed a tetrameric state in solution during purification (Fig. 1a, b, d). Further, we also detected VLLV-CARDaa1–101, similar to WT-CARDaa1–101, demonstrates an equilibrium between oligomers and monomers during gel-filtration purification (Fig. 6a, b), even though unlike WT-CARDaa1–101, the monomeric state appears to dominate for VLLV-CARDaa1–101. Among different truncations, only WT-CARDaa1–101 displayed a dynamic equilibrium between tetramers and monomers, whereas other truncations are monomers (Fig. 6c). Therefore, we hypothesized that the first ten residues are critical for its self-association when fused at the C terminus of MBP. To test whether the sequence of the first ten amino acids is required for CARD self-assembly, we replaced the first ten amino acids to a flexible GS repeat sequence (5′-GSGSGSGSGS-3′) in WT-CARDaa1–101. Compared with WT-CARDaa1–101, the GS repeat mutant showed no change in the tetramer peak (Fig. 6e). This suggests that a flexible loop at the N terminus, regardless of the sequence, is required for the oligomerization of CARD.
We also sought to find out the resting mechanism of caspase-11. We further hypothesized that there might exist some self-interaction between CARD and catalytic domain of caspase-11. Unfortunately, we failed to observe the interaction of the two units of caspase-11 (Fig. 6f). This result indicated there might be some more subtle mechanism of self-inhibition for caspase-11.
Discussion
We determined, for the first time, the crystal structure of the CARD domain in an inflammatory caspase. Our data show that the structure of caspase-11 CARD forms an atypical conformation different from other death domain superfamily members. And this conformation indicates a possible activation model of caspase-11 by the hydrophobic interaction mediated by CARD H1–2 (Fig. 7).
Death fold is generally packed loosely19 and several death domain members have non-classic structures during activation. For example, DR3 DD H3 and H4 undergo a conformation switch when interacting with tumor necrosis factor receptor-associated death domain17; FAD binding can induce the shift of helix H6 to H5 in Fas-associated protein with death domain, which forms a stem helix for the adaptor binding22. Therefore, the conformational changes of death domains are often associated with biological functions.
The constructs of caspase-11 CARD and full-length protein both with all mutants are linked with MBP on N-terminal side and His-tag on C-terminal side. The linker (VD) between MBP and the target protein was reported to have minimal impact on the structural and functional characteristics of the target protein23. Also, the linker brings the MBP tag closer to the CARD, which can stabilize the protein in the crystal (Supplementary Fig. S2). If removing the MBP tag after purification, we failed to obtain WT-CARDaa11–101 (data not shown). In contrast, the mutant VLLV-CARDaa11–101 is more stable in solution: it can be purified when the MBP tag in the N terminus is removed using TEV protease (Supplementary Fig. S3).
Inflammatory caspases (caspase-1/4/5/11) all contain a CARD and a catalytic domain14,24. Oligomerization caused by CARD–CARD interactions leads to self-cleavage, activation of the catalytic domain, cleavage of GSDMD, and the induction of pyroptosis. Our data show that the homotypic CARD–CARD interface mediated by hydrophobic residues in the elongated H1–2 is critical for the oligomerization of caspase-11 and its activation. Mutations on H1–2 could inhibit the aggregation of caspase-11 and reduce cell death induced by caspase-11. In addition, our results showed that LPS failed to bind with the MBP-tagged caspase-11 CARD. Maybe there also exist an intermediate molecular interaction that directly bind with caspase-11 in response to intracellular LPS stimulation or LPS only educated caspase-11 and then lead to activation. The N-terminal 1–59 residues of caspase-11 were reported to be critical for the activation of caspase-11 induced by LPS11. Our study further pinpointed that the H1–2 helix is essential for the oligomerization of caspase-11 during activation. This study of caspase-11 CARD structure and activation mechanism may provide insights into understanding the mechanism of inflammatory caspases in general and future drug development that aims to inhibit inflammasome activation.
Due to technical restrictions, we failed to solve the structure of full-length caspase-11 in resting state. In addition, the exact oligomerization state of full-length caspase-11 remains unknown. It is worth investigating whether the tetramer state observed in our CARD structure is maintained in full-length protein setting.
Materials and methods
Plasmids and transfection
Complementary DNA (cDNA) of murine caspase-11 was amplified from the plasmids provided by Feng Shao. The mutant and wild-type caspase-11 cDNAs were inserted into a pEGFP-N1 vector for transient expression in HEK293T cells. A modified pCDNA3.1 vector was used to co-express GSDMD with mutant and wild-type caspase-11 in HEK293T cells. All plasmids were verified by DNA sequencing.
Purification of recombinant proteins
E. coli Rosetta and BL21 (DE3) cells harboring the V28E-CARD plasmid (MBP vector with an N-terminal MBP tag and a C-terminal His6-tag) were grown in Luria-Bertani Broth (LB broth) medium supplemented with 50 μg/mL kanamycin. Protein expression was induced for 4 h at 18 °C with 0.3 mM isopropyl-β-d-thiogalactopyranoside after OD600 reached 1.2. The cells were collected by centrifugation and lysed by ultrasonication in a lysis buffer containing 150 mM NaCl, 20 mM imidazole, and 20 mM Tris-HCl (pH 8.0). The cell lysate was clarified by centrifugation at 15,000 × g at 4 °C for 20 min and residual debris was removed using a 0.8 μm filter. The supernatant containing the target protein was loaded onto a nickel column (GE Healthcare Life Sciences). The recombinant protein was eluted using the lysis buffer supplemented with 400 mM imidazole. The His6-MBP-tagged protein was further purified through Superdex 200 gel-filtration chromatography (GE Healthcare Life Sciences) in a buffer containing 250 mM NaCl and 10 mM Tris-HCl (pH 8.0).
Crystallization, X-ray diffraction, structure determination, and refinement
Purified MBP-tagged wild-type CARD protein was concentrated using Amicon centrifugal concentrators (Millipore) to 85 mg/mL. Then, hanging drops were set up for vapor diffusion crystallization. The protein was crystallized at 291 K for a week with a well solution containing 2.4 M ammonium sulfate and 5% isopropanol. Ethylene glycol was added to the reservoir solution to 20% (v/v) as the cryoprotectant and the crystals were flash-cooled in liquid nitrogen for X-ray diffraction data collection.
X-ray diffraction data were collected at the Shanghai Synchrotron Radiation Facility beamline BL17U125. Data were processed with the HKL2000 program suite26 and XDS27. The structure was determined using molecular replacement method and refined with the Phenix program suite28. The MBP structure from the Protein Data Bank (PDB ID: 4IRL) was used as the search model29. Model building was performed using Coot (Crystallographic Object-Oriented Toolkit). The structure was validated using the Molprobity server and the RCSB ADIT validation server before deposition. Figures were produced using the program Pymol (Schrödinger).
Antibodies and reagents
GSDMD antibody was obtained from Sigma-Aldrich (G7422). Glyceraldehyde 3-phosphate dehydrogenase antibody was obtained from ABclona (AC002). Horseradish peroxidase (HRP)-Goat anti-rabbit IgG (D110058) and HRP-Goat anti-mouse IgG (D110087) were purchased from BBI. Unlabeled ultrapure LPS from E. coli O111:B4 was purchased from Invitrogen. LDH release kit (C0017) was obtained from Beyotime.
Cell culture products were obtained from HyClone and fetal bovine serum (FBS) was obtained from Gibco.
Reverse transcription-quantitative PCR
Quantification of caspase-4 expression in 293T cells was performed with SYBR Green I PCR Master Mix (Takara) in the StepOne Plus Real-Time PCR System (ABI). The primers used for each gene examined are listed below. CASP4: 5′-CAGACTCTATGCAAGAGAAGCAACGTATGGCAGGA-3′ (forward) and 5′-CACCTCTGCAGGCCTGGACAATGATGAC-3′ (reverse); actin: 5′-CATGTACGTTGCTATCCAGGC-3′ (forward) and 5′-CTCCTTAATGTCACGCACGAT-3′ (reverse).
In vitro caspase-11 protease activity assay
The p20 and p10 fragments of the wild-type caspase-11 were obtained through expression and the auto-processing of the full-length caspase-11 in E. coli. Synthetic self-quenched fluorescence peptide substrate DABYL-GQLSLLSDGID-glu (2 μM, edans), which contains the caspase-11 cleavage site of GSDMD, was incubated with different concentrations of active caspase-11 in 200 μL buffer containing 150 mM NaCl, 1 mM EDTA, 10 mM dithiothreitol, and 50 mM HEPES (pH 7.4). The reactions were incubated for 30 min at room temperature prior to the measurement of fluorescence intensity using a BIOTEK microplate reader (Synergy H1).
Multi-angle light scattering
MALS measurements were carried out on a DAWN HELEOS 8+ instrument (Wyatt Technology) at room temperature. Caspase-11-CARD protein samples were diluted to 1 mg/mL in a buffer containing 250 mM NaCl and 10 mM Tris-HCl (pH 8.0) for analysis. The data were analyzed with the ASTRA software (Wyatt Technology).
The sedimentation velocity analytical ultracentrifugation
SV experiments were performed at 50,000 r.p.m. in a Proteomelab XL-A analytical ultracentrifuge (Beckman Coulter Instruments) at 20.0 °C at a wave length of 280 nm (lower concentration) and 250 nm (high concentration) using 12 mm double-sector cells. Protein solution of different concentration were used in a buffer containing 250 mM NaCl and 10 mM Tris-HCl (pH 8.0).
Total internal reflection fluorescence microscopy
HEK293T cells were transfected with plasmids encoding wild-type or mutant caspase-11. All cells were grown in growth media (high glucose Dulbecco’s modified Eagle’s medium with 10% FBS) and allowed to adhere overnight before transfection. Cells were analyzed 24 h after transfection. All samples were fixed with 4% paraformaldehyde in 1× phosphate-buffered saline for 15 min on ice. Samples were visualized with a Leica SR GSD microscope with a ×160 oil objective and a 100 nm penetration depth.
Statistical analysis
Data were analyzed using Prism (GraphPad Software, version 5.01).
Supplementary information
Acknowledgements
We thank the staff at GM/CA-CAT at the Advanced Photon Source (APS) and the BL17U1, BL18U, and BL19U1 beamline at Shanghai Synchrotron Radiation Facility (SSRF) for the assistance during data collection. T.J. is supported by the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB29030104), the National Natural Science Foundation of China (31870731 and U1732109), the Fundamental Research Funds for the Central Universities, and the 100 Talents Program of The Chinese Academy of Sciences.
Author contributions
M.L. conceived, designed, performed most experiments, and wrote the paper. K.Z., Z.X., X.C., X.Y., S.F., and K.N. contributed to data collection and analysis. H.M. and W.Z. discussed the experiment results and contributed to the discussion. A.Z. contributed to manuscript writing. X.Y., B.L., Y.Z., R.Z., and T.J. contributed to design, supervision, and finalized the manuscript.
Conflict of interest
The authors declare that they have no conflict of interest.
Footnotes
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Supplementary Information accompanies the paper at (10.1038/s41421-020-00201-w).
References
- 1.Chen H, Ning X, Jiang Z. Caspases control antiviral innate immunity. Cell. Mol. Immunol. 2017;14:736–747. doi: 10.1038/cmi.2017.44. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Broz P, et al. Caspase-11 increases susceptibility to Salmonella infection in the absence of caspase-1. Nature. 2012;490:288–291. doi: 10.1038/nature11419. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Case CL, et al. Caspase-11 stimulates rapid flagellin-independent pyroptosis in response to Legionella pneumophila. Proc. Natl Acad. Sci. USA. 2013;110:1851–1856. doi: 10.1073/pnas.1211521110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Casson, C. N. et al. Caspase-11 activation in response to bacterial secretion systems that access the host cytosol. PLoS Pathog. 9, e1003400 (2013). [DOI] [PMC free article] [PubMed]
- 5.Rathinam VAK, et al. TRIF licenses caspase-11-dependent NLRP3 inflammasome activation by gram-negative bacteria. Cell. 2012;150:606–619. doi: 10.1016/j.cell.2012.07.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Wang S, et al. Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE. Cell. 1998;92:501–509. doi: 10.1016/S0092-8674(00)80943-5. [DOI] [PubMed] [Google Scholar]
- 7.Hagar, J. A., Powell, D. A., Aachoui, Y., Ernst, R. K. & Miao, E. A. Cytoplasmic LPS activates caspase-11: implications in TLR4-independent endotoxic shock. Science341, 1250–1253 (2013). [DOI] [PMC free article] [PubMed]
- 8.Kayagaki N, et al. Noncanonical inflammasome activation by intracellular LPS independent of TLR4. Science (80) 2013;341:1246–1249. doi: 10.1126/science.1240248. [DOI] [PubMed] [Google Scholar]
- 9.Kayagaki N, et al. Non-canonical inflammasome activation targets caspase-11. Nature. 2011;479:117–121. doi: 10.1038/nature10558. [DOI] [PubMed] [Google Scholar]
- 10.Lee BL, et al. Caspase-11 auto-proteolysis is crucial for noncanonical inflammasome activation. J. Exp. Med. 2018;215:2279–2288. doi: 10.1084/jem.20180589. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Shi J, et al. Inflammatory caspases are innate immune receptors for intracellular LPS. Nature. 2014;514:187–192. doi: 10.1038/nature13683. [DOI] [PubMed] [Google Scholar]
- 12.Kayagaki N, et al. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature. 2015;526:666–671. doi: 10.1038/nature15541. [DOI] [PubMed] [Google Scholar]
- 13.Shi J, et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature. 2015;526:660–665. doi: 10.1038/nature15514. [DOI] [PubMed] [Google Scholar]
- 14.Wang SY, et al. Identification and characterization of Ich-3, a member of the interleukin-1-beta converting enzyme (Ice) Ced-3 family and an upstream regulator of ice. J. Biol. Chem. 1996;271:20580. doi: 10.1074/jbc.271.34.20580. [DOI] [PubMed] [Google Scholar]
- 15.Lamkanfi M, Dixit VM. Inflammasomes and their roles in health and disease. Annu. Rev. Cell Dev. Biol. 2012 doi: 10.1146/annurev-cellbio-101011-155745. [DOI] [PubMed] [Google Scholar]
- 16.Riedl SJ, Salvesen GS. The apoptosome: signalling platform of cell death. Nat. Rev. Mol. Cell Biol. 2007;8:405–413. doi: 10.1038/nrm2153. [DOI] [PubMed] [Google Scholar]
- 17.Yin X, et al. Crystal structure and activation mechanism of DR3 death domain. FEBS J. 2019;286:2593–2610. doi: 10.1111/febs.14834. [DOI] [PubMed] [Google Scholar]
- 18.Shen C, et al. Molecular mechanism for NLRP6 inflammasome assembly and activation. Proc. Natl Acad. Sci. USA. 2019;116:2052–2057. doi: 10.1073/pnas.1817221116. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Park HH, et al. The death domain superfamily in intracellular signaling of apoptosis and inflammation. Annu. Rev. Immunol. 2007;25:561–586. doi: 10.1146/annurev.immunol.25.022106.141656. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Krissinel E, Henrick K. Inference of macromolecular assemblies from crystalline state. J. Mol. Biol. 2007;372:774–797. doi: 10.1016/j.jmb.2007.05.022. [DOI] [PubMed] [Google Scholar]
- 21.Chu, L. H. et al. The oxidized phospholipid oxPAPC protects from septic shock by targeting the non-canonical inflammasome in macrophages. Nat. Commun. 9, 996 (2018). [DOI] [PMC free article] [PubMed]
- 22.Scott FL, et al. The Fas – FADD death domain complex structure unravels signalling by receptor clustering. Nature. 2009;457:1019–1022. doi: 10.1038/nature07606. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Jin, T. et al. Design of an expression system to enhance MBP-mediated crystallization. Sci. Rep. 7, 40991 (2017). [DOI] [PMC free article] [PubMed]
- 24.Martinon F, Tschopp J. Inflammatory caspases and inflammasomes: master switches of inflammation. Cell Death Differ. 2007;14:10–22. doi: 10.1038/sj.cdd.4402038. [DOI] [PubMed] [Google Scholar]
- 25.Wang, Q. S. et al. Upgrade of macromolecular crystallography beamline BL17U1 at SSRF. Nucl. Sci. Tech. 29, 68 (2018).
- 26.Otwinowski Z, Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 1997;276:307–326. doi: 10.1016/S0076-6879(97)76066-X. [DOI] [PubMed] [Google Scholar]
- 27.Kabsch W, et al. XDS. Acta Crystallogr. Sect. D. Biol. Crystallogr. 2010;66:125–132. doi: 10.1107/S0907444909047337. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution, 10.1107/97809553602060000865 (2012). [DOI] [PMC free article] [PubMed]
- 29.Jin T, Huang M, Smith P, Jiang J, Xiao TS. Structure of the caspase-recruitment domain from a zebrafish guanylate-binding protein. Acta Crystallogr. Sect. F. Struct. Biol. Cryst. Commun. 2013;69:855–860. doi: 10.1107/S1744309113015558. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.